Company Description

Pano, formerly NovaTarg Therapeutics, is a biotech platform and preclinical stage company focused on the discovery and development of small molecules targeting dysregulated cellular energetics to treat orphan diseases, highly prevalent chronic diseases, and even the aging process itself.